This list is an analysis based on recent market events. It's not an investment recommendation.
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Show more...
FAQ
What is RESPONSE ONCOLOGY INC stock price today?▼
The current price of ROIX is $0.00 USD — it has increased by +0% in the past 24 hours. Watch RESPONSE ONCOLOGY INC stock price performance more closely on the chart.
What is RESPONSE ONCOLOGY INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC MARKETS exchange RESPONSE ONCOLOGY INC stocks are traded under the ticker ROIX.
What is RESPONSE ONCOLOGY INC market cap?▼
Today RESPONSE ONCOLOGY INC has the market capitalization of 12.18
How many employees does RESPONSE ONCOLOGY INC have?▼
As of September 09, 2026, the company has 10 employees.
In which sector is RESPONSE ONCOLOGY INC located?▼
RESPONSE ONCOLOGY INC operates in the Health & Wellness sector.
When did RESPONSE ONCOLOGY INC complete a stock split?▼
RESPONSE ONCOLOGY INC has not had any recent stock splits.